Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Japanese encephalitis
NITAG documentation
Adults
Clear all
Type of publications
NITAG documentation
(5)
Systematic reviews (SYSVAC)
(467)
Topics
Agenda & Minutes
(2)
Recommendation
(3)
Regions
Americas
(3)
Europe
(1)
Western Pacific
(1)
Countries
Australia
(1)
Belgium
(1)
Canada
(1)
United States of America
(2)
Diseases
COVID-19
(3)
Japanese encephalitis
(2)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(4)
Rabies
(1)
Publication date
2021
(3)
2018
(1)
2017
(1)
Target population
Adults
(5)
Adolescents
(4)
Children
(8)
Healthcare workers
(4)
Newborn
(1)
Older adults
(4)
Available to download in languages
English (EN)
(4)
French (FR)
(1)
5 results found
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
2021
∙
Conseil Supérieur de la Santé (CSS)
Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy
2018
∙
ACIP
October 2018 - meeting minutes
2017
∙
ACIP
October 2017 - meeting minutes
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register